Co-Authors
This is a "connection" page, showing publications co-authored by Markus Neurath and Michael Sticherling.
Connection Strength
0.335
-
COVID-19: risk for cytokine targeting in chronic inflammatory diseases? Nat Rev Immunol. 2020 05; 20(5):271-272.
Score: 0.220
-
SARS-CoV-2 vaccination responses in untreated, conventionally treated and anticytokine-treated patients with immune-mediated inflammatory diseases. Ann Rheum Dis. 2021 10; 80(10):1312-1316.
Score: 0.059
-
Patients with immune-mediated inflammatory diseases receiving cytokine inhibitors have low prevalence of SARS-CoV-2 seroconversion. Nat Commun. 2020 07 24; 11(1):3774.
Score: 0.056